UB Paderborn / Katalog / Suche / in CDI

A parallel integrated learning technique of improved particle swarm optimization and BP neural network and its application

Scientific reports, 2022-11, Vol.12 (1), p.19325-17, Article 19325

2022

Volltextzugriff (PDF)

A Hybrid Model for Financial Time Series Forecasting-Integration of EWT, ARIMA With The Improved ABC Optimized ELM

IEEE access, 2020, Vol.8, p.84501-84518

2020

Volltextzugriff (PDF)

Research on Credit Risk Measurement of Small and Micro Enterprises Based on the Integrated Algorithm of Improved GSO and ELM

Mathematical problems in engineering, 2020-09, Vol.2020, p.1-14

2020

Volltextzugriff (PDF)

Polycentric structure and carbon dioxide emissions: Empirical analysis from provincial data in China

Journal of cleaner production, 2021-01, Vol.278, p.123411, Article 123411

2021

Volltextzugriff (PDF)

CUS-heterogeneous ensemble-based financial distress prediction for imbalanced dataset with ensemble feature selection

Applied soft computing, 2020-12, Vol.97, p.106758, Article 106758

2020

Volltextzugriff (PDF)

The study of firm productivity with green credit policies: evidence from Chinese industrial firms

Total quality management & business excellence, 2024-02, Vol.35 (3-4), p.428-449

2024

Volltextzugriff (PDF)

The characteristics of the new dual-cycle development pattern and systemic financial risk based on TVP-SVAR and MS-VAR model analyses

Heliyon, 2024-08, Vol.10 (15), p.e34943, Article e34943

2024

Volltextzugriff (PDF)

Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles

Journal of medicinal chemistry, 2009-06, Vol.52 (12), p.3679-3688

2009

Volltextzugriff (PDF)

Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitors

Bioorganic & medicinal chemistry letters, 2010-03, Vol.20 (5), p.1689-1692

2010

Volltextzugriff (PDF)

Discovery of SCH446211 (SCH6): A New Ketoamide Inhibitor of the HCV NS3 Serine Protease and HCV Subgenomic RNA Replication

Journal of medicinal chemistry, 2006-05, Vol.49 (9), p.2750-2757

2006

Volltextzugriff (PDF)

Deep Learning Based on Hierarchical Self-Attention for Finance Distress Prediction Incorporating Text

Computational intelligence and neuroscience, 2021, Vol.2021 (1), p.1165296-1165296

2021

Volltextzugriff (PDF)

Inferring to individual diversity promotes the cooperation in the spatial prisoner’s dilemma game

Chaos, solitons and fractals, 2015-02, Vol.71, p.91-99

2015

Volltextzugriff (PDF)

Structure-Based Design of a General Class of Mechanism-Based Inhibitors of the Serine Proteinases Employing a Novel Amino Acid-Derived Heterocyclic Scaffold

Biochemistry (Easton), 1997-04, Vol.36 (16), p.4739-4750

1997

Volltextzugriff (PDF)

Inhibition of serine proteases by functionalized sulfonamides coupled to the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold

Bioorganic & medicinal chemistry, 2001-06, Vol.9 (6), p.1543-1548

2001

Volltextzugriff (PDF)

Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates

Bioorganic & medicinal chemistry, 2000-05, Vol.8 (5), p.1005-1016

2000

Volltextzugriff (PDF)

Depeptidization efforts on P3–P2′ α-ketoamide inhibitors of HCV NS3-4A serine protease: Effect on HCV replicon activity

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (6), p.1621-1627

2006

Volltextzugriff (PDF)

Discovery of (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection

Journal of medicinal chemistry, 2006-10, Vol.49 (20), p.6074-6086

2006

Volltextzugriff (PDF)

Use of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide and isothiazolidin-3-one 1,1 dioxide scaffolds in the design of potent inhibitors of serine proteinases

Bioorganic & medicinal chemistry letters, 1998-03, Vol.8 (5), p.539-544

1998

Volltextzugriff (PDF)

Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P 4 -Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles

Journal of medicinal chemistry, 2009-06, Vol.52 (12), p.3679-3688

2009

Volltextzugriff (PDF)

Depeptidization efforts on P[subscript 3]-P[prime subscript 2] [alpha]-ketoamide inhibitors of HCV NS3-4A serine protease: Effect on HCV replicon activity

Bioorganic & medicinal chemistry letters, 2008-06, Vol.16 ((6) ; 03, 2006)

2008

Volltextzugriff (PDF)

Potent and Specific Inhibition of Human Leukocyte Elastase, Cathepsin G and Proteinase 3 by Sulfone Derivatives Employing the 1,2,5-Thiadiazolidin-3-one 1,1 Dioxide Scaffold

Bioorganic & medicinal chemistry, 1998-06, Vol.6 (6), p.661-671

1998

Volltextzugriff (PDF)

A General Inhibitor Scaffold for Serine Proteases with a (Chymo)trypsin-Like Fold: Solution-Phase Construction and Evaluation of the First Series of Libraries of Mechanism-Based Inhibitors

Journal of the American Chemical Society, 1999-09, Vol.121 (35), p.8128-8129

1999

Volltextzugriff (PDF)

Depeptidization efforts on α-ketoamide inhibitors of HCV NS3-4A serine protease: Effect on HCV replicon activity

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (6), p.1621-1627

2006

Volltextzugriff (PDF)

1,2,5-Thiadiazolidin-3-one 1,1 Dioxide: A Powerful Scaffold for Probing the S′ Subsites of (Chymo)trypsin-Like Serine Proteases

Archives of biochemistry and biophysics, 2001-01, Vol.385 (1), p.162-169

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A parallel integrated learning technique of improved particle swarm optimization and BP neural network and its application

A Hybrid Model for Financial Time Series Forecasting-Integration of EWT, ARIMA With The Improved ABC Optimized ELM

Research on Credit Risk Measurement of Small and Micro Enterprises Based on the Integrated Algorithm of Improved GSO and ELM

Polycentric structure and carbon dioxide emissions: Empirical analysis from provincial data in China

CUS-heterogeneous ensemble-based financial distress prediction for imbalanced dataset with ensemble feature selection

The study of firm productivity with green credit policies: evidence from Chinese industrial firms

Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor

The characteristics of the new dual-cycle development pattern and systemic financial risk based on TVP-SVAR and MS-VAR model analyses

Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles

Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitors

Discovery of SCH446211 (SCH6): A New Ketoamide Inhibitor of the HCV NS3 Serine Protease and HCV Subgenomic RNA Replication

Deep Learning Based on Hierarchical Self-Attention for Finance Distress Prediction Incorporating Text

Inferring to individual diversity promotes the cooperation in the spatial prisoner’s dilemma game

Structure-Based Design of a General Class of Mechanism-Based Inhibitors of the Serine Proteinases Employing a Novel Amino Acid-Derived Heterocyclic Scaffold

Inhibition of serine proteases by functionalized sulfonamides coupled to the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold

Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates

Depeptidization efforts on P3–P2′ α-ketoamide inhibitors of HCV NS3-4A serine protease: Effect on HCV replicon activity

Use of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide and isothiazolidin-3-one 1,1 dioxide scaffolds in the design of potent inhibitors of serine proteinases

Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P 4 -Capped Ketoamide Inhibitors of Hepatitis C Virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles

Depeptidization efforts on P[subscript 3]-P[prime subscript 2] [alpha]-ketoamide inhibitors of HCV NS3-4A serine protease: Effect on HCV replicon activity

Potent and Specific Inhibition of Human Leukocyte Elastase, Cathepsin G and Proteinase 3 by Sulfone Derivatives Employing the 1,2,5-Thiadiazolidin-3-one 1,1 Dioxide Scaffold

A General Inhibitor Scaffold for Serine Proteases with a (Chymo)trypsin-Like Fold: Solution-Phase Construction and Evaluation of the First Series of Libraries of Mechanism-Based Inhibitors

Depeptidization efforts on α-ketoamide inhibitors of HCV NS3-4A serine protease: Effect on HCV replicon activity

1,2,5-Thiadiazolidin-3-one 1,1 Dioxide: A Powerful Scaffold for Probing the S′ Subsites of (Chymo)trypsin-Like Serine Proteases

Suchergebnisse filtern